A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
Lim, S H, Kim, T W, Hong, Y S, Han, S-W, Lee, K-H, Kang, H J, Hwang, I G, Lee, J Y, Kim, H S, Kim, S T, Lee, J, Park, J O, Park, S H, Park, Y S, Lim, H Y, Jung, S-H, Kang, W KLanguage:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2015.371
Date:
October, 2015
File:
PDF, 304 KB
english, 2015
File converter
More search results
More benefits 
